Cannabis Bioscience International Holdings EBITDA Growth & History (CBIH)

Cannabis Bioscience International Holdings's calculated EBITDA was −$335,529 for fiscal 2025.

View full Cannabis Bioscience International Holdings company overview

Cannabis Bioscience International Holdings annual ebitda history

Cannabis Bioscience International Holdings annual ebitda

Fiscal yearPeriod endedEBITDAChangeGrowth
20252025-05-31−$335,529$150,611—
20242024-05-31−$486,140$419,088—
20232023-05-31−$905,228——

Cannabis Bioscience International Holdings ebitda trends

Between the periods ended 2023-05-31 and 2025-05-31, Cannabis Bioscience International Holdings's ebitda increased from −$905,228 to −$335,529, a change of $569,699. The latest reported quarter, Q3 2026, shows −$93,158.

About the metric

What EBITDA means

EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.

Calculation and source

How TickerStat calculates EBITDA

TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cannabis Bioscience International Holdings source filings ↗

Community posts

It’s quiet here.

No posts about CBIH yet. Start the conversation.

Write the first post